What Your Apple Watch Is Trying to Tell You (And When to Listen)

A Cardiologist’s Guide to Wearable Heart Data

By Dr. Job Mogire, MD, FACP, FACC

Opening Scene

It is 2:04 in the morning.

Marcus is 52 years old, VP of operations at a logistics company, 187 pounds, runs a 5K twice a week. He went to bed at 10:30, which he considers responsible. His Apple Watch Series 9 sits on the wireless charger next to his water glass. His phone buzzes. The screen lights up with a notification he has never seen before:

Irregular rhythm detected. Possible atrial fibrillation.

He picks it up. Reads it twice. His first thought: it must be an error, he was asleep and not even wearing the watch. His second thought: I could be having a heart attack.

He opens Safari. Types “Apple Watch atrial fibrillation notification” at 2:06 AM. The first result is Apple’s support page (technology explanation, no clinical guidance). The second is a WebMD article about what AFib feels like. The third is a Reddit thread where eighteen people with no medical credentials debate whether to go to the ER.

He finds nothing from a cardiologist.

By 2:30, he has read six articles and is more confused. He does not know whether this notification means he has AFib, means he almost had a stroke, or means the watch detected ectopic beats while he shifted position. He does not know these are three entirely different situations requiring three entirely different responses. One warrants an ER visit. Two warrant going back to sleep.

He sets his phone face-down at 2:47 and stares at the ceiling.

More than sixty million Americans use some form of wearable health monitor. These devices generate data continuously, send notifications without warning, and exist in a clinical interpretation void. Device companies explain what their algorithms detect. Fitness coaches explain what heart rate variability means for recovery. Nobody explains what a cardiologist does with this data, which alerts actually matter, and which can safely be filed under “the watch was confused.”

As a board-certified cardiologist (FACC), I want to fill that void: not with a technology tutorial, but with a clinical framework for when to be worried, when to wait, and when the number on your wrist is simply not the number that matters.

What Most Men Hide About Their Wearable Data

The competitive use of wearable metrics among men is something I observe constantly, both in clinical practice and in the circles where health-conscious men actually talk to each other. It runs like this: someone mentions their resting heart rate is 52. Someone else says theirs is 48. A third person pulls out their phone to prove his HRV averaged 71 milliseconds last month.

The data becomes a leaderboard. The leaderboard becomes an identity.

What men do not say out loud, what I hear in exam rooms when the door is closed and the chart is already open, is the fear underneath the competition. “I’ve been tracking my Whoop for eight months and I’m terrified it’s eventually going to show me something I can’t unknow.” One patient, a 47-year-old attorney who wore a Whoop band every day for two years, told me: “I’ve been afraid to look at the cardiovascular section for the last three months. I just track the sleep score and close the app.”

The online forums reflect the same pattern. On Reddit’s r/whoop community, threads titled “Is a low HRV a cardiac problem?” and “My Whoop coach hasn’t provided me with a definitive explanation” accumulate hundreds of responses from users with no clinical background. “Is HRV of 20 bad?” generates over 14,000 monthly searches. “Apple Watch AFib notification what to do” generates more than 22,000. These are not curiosity searches. They are 2 AM searches by frightened people looking for a cardiologist who will talk plainly.

The fear runs in two registers. The acute: the irregular rhythm notification, the high heart rate alert, the feeling that something is wrong right now. The chronic: the quiet dread that six months of low HRV scores, or a resting heart rate that crept up twelve beats over the past year, means something serious no one has translated.

Both deserve a direct answer. The wearable industry has not provided one. The fitness optimization space has not either. That gap is exactly where I work.

The Mechanism: In Plain English

What Wearables Actually Measure

Modern consumer wearables use two primary sensing technologies. Photoplethysmography (PPG): a green LED shines light into your skin, a sensor measures how much light bounces back, and the pulse wave of each heartbeat registers as a change in reflectance. This is how your watch measures resting heart rate and basic HRV. Electrical sensing via electrodes: when you press your finger on the Apple Watch crown, you complete an electrical circuit across your chest, generating an ECG trace equivalent to a single lead.

Heart rate by PPG is genuinely accurate at rest. A 2019 validation study across multiple devices found mean absolute percentage errors of 1 to 5 percent (Shcherbina et al., npj Digital Medicine, https://doi.org/10.1038/s41746-017-0020-3). Resting heart rate as measured by a consumer wearable correlates with ECG-derived resting heart rate at greater than 95 percent accuracy in controlled settings, reliable for trend monitoring over weeks and months, not reliable enough to diagnose arrhythmias or replace a clinic visit.

During high-intensity exercise, accuracy degrades. Movement artifact, skin tone variation, and wrist positioning all introduce error. The watch you trust at rest is making more mistakes during your sprint intervals than its confidence display suggests.

The AFib Question

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting more than six million Americans. It carries a fivefold increased risk of stroke. So the question “can my watch detect AFib?” is not a vanity question. It is a medical question with real consequences.

The Apple Heart Study enrolled 419,093 participants (Perez et al., JACC, https://doi.org/10.1016/j.jacc.2019.08.024). Among those who received an irregular pulse notification, 84 percent were confirmed to have AFib on ECG patch monitoring, a positive predictive value of 0.84. That sounds reassuring. Read the other number. Only 0.5 percent of all participants received a notification. The algorithm is calibrated to avoid false positives by setting a very high threshold. In a mostly healthy, low-prevalence population, the watch stays quiet even when AFib is occasionally present.

The Fitbit Heart Study, published in the New England Journal of Medicine in 2021 (Perez et al., NEJM, https://doi.org/10.1056/NEJMoa2025197), found photoplethysmography-based AFib detection achieved 98 percent specificity but only 67 percent sensitivity across 455,699 participants. The watch is more likely to miss AFib than to falsely diagnose it.

When your watch flags an irregular rhythm, take it seriously. When it stays silent, do not assume your heart is fine.

The Apple Watch Series 4 and later can generate a single-lead ECG strip via the electrical sensing function: essentially a lead I equivalent from wrist to finger. This is meaningfully different from passive PPG rhythm monitoring. A single-lead trace can help identify AFib with greater confidence than a passive alert. It is not a 12-lead ECG. It cannot assess the ST segments I care about, evaluate bundle branch blocks, or detect chamber hypertrophy. The watch gives me one slice. I need twelve to read the full story.

In my clinical practice, when a patient brings me a wearable notification, I do not dismiss it and I do not diagnose from it. I use it as the starting point for a conversation about symptoms, context, and whether the clinical picture warrants a Holter monitor, a referral, or reassurance.

HRV: The Misunderstood Number

Heart rate variability is the variation in time between consecutive heartbeats, measured in milliseconds. It reflects the balance between your sympathetic nervous system (the accelerator) and your parasympathetic nervous system (the brake). Higher HRV, broadly speaking, reflects a body at rest and in recovery. Lower HRV reflects stress, illness, poor sleep, or high training load.

The fitness optimization community has turned HRV into a morning ritual. Whoop wakes you up with a recovery score. Andrew Huberman’s audience tracks HRV as nervous system state. Peter Attia’s readers use it as a supplement response metric. None of them are wrong that HRV is interesting. They are using a different lens than I use.

Low HRV as a chronic pattern is associated with increased cardiovascular mortality in post-MI patients and in populations with established disease (Thayer et al., International Journal of Cardiology, https://doi.org/10.1016/j.ijcard.2010.09.019). In a healthy 45-year-old with no known cardiac disease, a single morning reading of 22 milliseconds is almost certainly noise from poor sleep, dehydration, or one too many glasses of wine. It is not a cardiac diagnosis without a personal baseline established over at least three to four weeks.

HRV for cardiovascular risk stratification belongs in the Early evidence category: interesting trends, preliminary associations, not ready to guide clinical decisions without blood pressure, lipid panel, ApoB, CAC score, family history, and a 12-lead ECG. None of which your Whoop can measure.

What No Wearable Can See

The question I answer most often in practice: “Since I have all this data, can I skip the cardiology workup?”

No.

Your $399 Oura ring cannot measure ApoB, coronary artery calcium score, carotid intima-media thickness, structural heart disease, LAD stenosis, ejection fraction, or practically any condition I worry about most in men in their forties and fifties. A 50-year-old with perfect Whoop recovery scores can have silent LAD disease building for a decade. The CAC score sees it. The wearable does not. They are tools for completely different questions.

The Honesty Scale

Wearable resting heart rate accuracy: Solid (1). Validated against gold-standard ECG across multiple device types and populations. Useful for trend monitoring. Reliable enough for clinical context.

Wearable AFib detection via single-lead ECG (Apple Watch Series 4+, AliveCor Kardia): Promising (2). PPV of approximately 84 percent in the Apple Heart Study. Useful as a screening tool to prompt clinical evaluation. Not a replacement for Holter monitoring or a 12-lead ECG. The distinction between AFib, PACs, and artifact requires clinical judgment.

Passive PPG-based AFib detection (all devices): Promising (2) with important caveats. High specificity (98%) but lower sensitivity (67%). Better for ruling in than ruling out. Will miss roughly one in three AFib cases.

HRV for cardiovascular risk stratification in healthy adults: Early (3). Promising associations in high-risk populations. Insufficient evidence to guide clinical decision-making in asymptomatic individuals without established cardiac disease. Consumer wearable HRV measurement methodology varies significantly across devices, which further limits cross-device comparisons.

Wearable sleep architecture and sleep apnea detection: Early (3). Wearables can estimate sleep duration and rough stage classifications with moderate correlation to polysomnography. They cannot diagnose obstructive sleep apnea. If your Oura ring says your sleep is fine but your bed partner reports apneic episodes or you wake unrefreshed, that clinical picture overrides the algorithm.

Wearable VO2 max estimation: Promising (2) for relative tracking in the same individual over time. Less reliable as an absolute number for clinical comparison.

What the Other Voices Get Wrong

The digital landscape on wearable health data is dominated by three categories: device companies, fitness optimization influencers, and generic health publications. Each has a specific blind spot.

Apple, Garmin, Whoop, and Oura produce excellent hardware documentation and well-written algorithm explanations. They will not tell you that their notification might be wrong, under what conditions their data becomes unreliable, or what to do when the algorithm flags something that changes your morning. Their business model requires user confidence in the product. Clinical precision about device limitations is not compatible with that business model. Apple’s health website (https://www.apple.com/health/) is instructive for feature explanations and genuinely unhelpful for clinical interpretation.

Andy Galpin (https://www.andygalpin.com) is a genuine exercise physiologist. His HRV content is accurate within its domain: he uses it as a training load variable and explains the physiology clearly. What his platform does not address is the gap between “HRV as training variable” and “HRV as cardiovascular disease signal.” A 52-year-old with declining HRV and a family history of early coronary disease needs a cardiologist’s assessment, not a training modification.

Bryan Johnson (https://protocol.bryanjohnson.com) publishes his entire health protocol publicly, including extensive wearable data. The transparency has value. It also creates a confounding dynamic: a billionaire with a medical team and daily lab draws publishes his wearable numbers, and readers without that infrastructure internalize the metrics as applicable to their own situation. The framework does not transfer. Johnson’s team can interpret his data in the context of real-time labs and clinical oversight. His readers cannot.

Rhonda Patrick (https://www.foundmyfitness.com) uses HRV as a supplement response metric, tracking how sauna, cold exposure, and specific nutrients affect scores. No cardiologist would use a supplement’s HRV effect as a clinical outcome measure without correlating it with structural cardiac data. The metric is being asked to do more work than the evidence supports.

The gap none of these voices fill: what to do at 2 AM when the notification says “possible atrial fibrillation,” how to distinguish a PAC from dangerous arrhythmia, and when wearable data belongs in a cardiology conversation.

Cardiologist’s Note

The following is a clinical sidebar, not a substitute for evaluation.

When a patient brings me their wearable data, I look for three things: trends, not points; context, not scores; and alerts, not averages.

A single HRV reading of 18 milliseconds means nothing to me. Eight weeks of declining HRV combined with new exertional fatigue and a resting heart rate trending up 10 beats per minute tells me something worth investigating.

When a patient shows me an irregular rhythm notification, my first question is: “Did you have symptoms at the time?” Palpitations, lightheadedness, or chest pressure in the context of an alert changes my urgency immediately. An asymptomatic notification during sleep in a healthy 48-year-old is a different conversation than the same notification in someone with a family history of sudden cardiac death.

Before any cardiology visit: export a 30-day trend summary, note any dates with unusual symptoms, and bring both. Your cardiologist can correlate device data with clinical history in ways Google Search cannot.

Do not interpret a high-risk notification in isolation. Do not delay evaluation because the watch “only” flagged something once. Do not assume clean wearable metrics mean a clean cardiac bill of health.

The watch sees the surface. I see what’s underneath.

What to Do This Week

The goal here is not to turn you into a wearable data analyst. The goal is to give you a framework for using what you already have, knowing its limits, and knowing exactly when to escalate.

1. Establish your personal HRV baseline before interpreting any single reading. HRV is meaningful as a trend within your own physiology, not as a comparison to someone else’s numbers. Track it for 21 consecutive mornings under consistent conditions and calculate your mean. That number becomes your reference point. A reading more than 20 percent below your baseline warrants noting alongside sleep quality, stress, and any symptoms. One abnormal reading means almost nothing.

2. Know the difference between a passive rhythm alert and an ECG-based notification. If your Apple Watch Series 4 or later generated an ECG trace using the digital crown function, save that trace in the Health app. Screenshot it. Bring it to your next appointment. This is meaningfully more useful to a cardiologist than a passive background notification. If your watch simply buzzed and told you your rhythm seemed irregular, that is the lower-confidence signal, worth documenting but not worth a 3 AM ER trip in the absence of symptoms.

3. Apply the symptom test to every cardiac alert. When you get a rhythm notification, ask yourself immediately: Am I having chest pressure or chest pain? Am I lightheaded or about to faint? Am I short of breath at rest? If yes to any of these, call emergency services. If no, document the time, what you were doing, and whether you felt anything unusual, then call your cardiologist’s office in the morning. The wearable alert with symptoms is a medical urgency. The wearable alert without symptoms is a scheduled conversation.

4. Track resting heart rate trend weekly, not daily. Resting heart rate varies two to five beats per minute daily based on hydration, stress, and sleep. What matters clinically is a sustained directional shift over four to eight weeks. A 10-beat rise that holds for six weeks warrants a conversation about thyroid function, anemia, and cardiac output. The trend reveals what a single data point conceals.

5. Do not let clean wearable scores substitute for a cardiac workup. If you are a man over 40 with no known cardiac disease who has never had a coronary artery calcium score, that gap matters more than anything your Oura ring has measured. Book the CAC score. Schedule the lipid panel with ApoB. The wearable covers rhythm and recovery. The CAC score covers the arteries. You need both.

6. Export 90 days of data before your annual physical. Apple Health exports to PDF. Whoop and Oura export CSV. Organize 90 days of resting heart rate trend, HRV average, sleep duration, and any alerts with dates. Twenty minutes of prep makes a clinical visit dramatically more productive.

7. Apply the same framework when a family member gets an alert. Symptom test first. Escalate on symptoms. Document and schedule on no symptoms.

The Featured Snippet Block

What should you do when your Apple Watch detects possible atrial fibrillation?

If you have chest pain, dizziness, or shortness of breath alongside the notification, seek emergency care immediately. If you have no symptoms, document the time and context, save any ECG trace in your Health app, and contact your cardiologist within 24 hours. A single notification without symptoms is not a diagnosis, but it warrants clinical evaluation.

When to Call Your Cardiologist

There is a version of this conversation that ends with men feeling reassured about every wearable alert, and a version that ends with men in the emergency room every time the watch buzzes. I am not interested in either outcome.

Schedule an appointment within one to two weeks if:

Your watch has flagged an irregular rhythm more than once, even without symptoms. One alert is noise. Two alerts in a month is a pattern worth a Holter monitor.

Your resting heart rate has risen more than 10 beats per minute above baseline and stayed there for more than two weeks without obvious cause.

Your HRV has declined more than 20 percent from your personal baseline for three or more weeks alongside fatigue on exertion, reduced exercise tolerance, or unexplained breathlessness.

Your wearable picks up irregular rhythm at night and you have never been screened for sleep apnea. AFib and obstructive sleep apnea overlap significantly, and treating apnea reduces AFib recurrence.

Go to the emergency room or call 911 immediately if:

You receive a cardiac alert with chest pain or pressure, lightheadedness, sudden shortness of breath, or palpitations you can feel strongly. Do not drive yourself. Do not search Reddit. Call.

The watch saw something. I will tell you what it means.

The Close

Marcus did fall back to sleep that night. He called his physician two days later, who ordered a 14-day cardiac event monitor. The monitor captured two brief runs of paroxysmal AFib, both under 30 seconds, both asymptomatic. His cardiologist assessed his CHADS-VASc score, ran an echocardiogram to rule out structural disease, and determined anticoagulation was not yet indicated. He got answers in three weeks that no wearable and no search engine had been able to provide in eighteen months of continuous data collection.

That is the gap I exist to close.

The wearable was not wrong to generate the alert. The alert was not meaningless because it was asymptomatic. The data was not useless because the app could not interpret it. What was missing was a cardiologist who could stand between the notification and the panic and say: here is what this means, here is what it does not mean, and here is what we do next.

If you have months of wearable data and no idea what it means for your cardiovascular risk, start with the Vascular Clock Starter Kit: taking the data you already have and putting it in the context of the cardiac metrics that actually predict outcomes. First step in a clinical framework, not a replacement for one.

Your watch is recording. It is time to have someone read the recording.

Download the Vascular Clock Starter Kit: the cardiologist’s guide to what your wearable data means, what it cannot tell you, and the five tests that see what no algorithm can.

Dr. Job Mogire, MD, FACP, FACC, is a board-certified cardiologist practicing in Urbana, Illinois. He writes on cardiovascular health, longevity science, and clinical reasoning at the Slow Down and Evolve platform.

Sources cited in this article:

• Shcherbina et al. (2017). Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort. npj Digital Medicine. https://doi.org/10.1038/s41746-017-0020-3
• Perez et al. (2019). Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation. NEJM. https://doi.org/10.1056/NEJMoa1901183
• Perez et al. (2019). Apple Heart Study. JACC. https://doi.org/10.1016/j.jacc.2019.08.024
• Thayer et al. (2010). The Relationship of Autonomic Imbalance, Heart Rate Variability, and Cardiovascular Disease Risk Factors. International Journal of Cardiology. https://doi.org/10.1016/j.ijcard.2010.09.019